CIK 0001822791 · Non-accelerated filer<br>Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 852828339
- Phone
- 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-22 | Mosca Alison Director | Grant or award · Stock Options (Right to buy) | +1,500 | 1,500 | ||
| 2025-05-22 | Mosca Alison Director | Grant or award · Stock Options (Right to buy) | +7,984 | 7,984 | ||
| 2025-05-22 | McLaughlin Vallerie Director | Grant or award · Stock Options (Right to buy) | +1,500 | 1,500 | ||
| 2025-05-22 | McLaughlin Vallerie Director | Grant or award · Stock Options (Right to buy) | +5,759 | 5,759 | ||
| 2025-05-22 | WILCOX REED N Director | Grant or award · Stock Options (Right to buy) | +1,500 | 1,500 | ||
| 2025-05-22 | WILCOX REED N Director | Grant or award · Stock Options (Right to buy) | +5,236 | 5,236 | ||
| 2025-03-19 | General Resonance LLC 10% owner | Sale | −1,400 | $4.40 | $6K | 710,852 |
| 2025-03-18 | General Resonance LLC 10% owner | Sale | −1,333 | $4.45 | $6K | 712,252 |
| 2025-02-27 | WILCOX REED N Director | Grant or award · Stock Options (Right to buy) | +2,886 | 2,886 | ||
| 2025-02-27 | Mosca Alison Director | Grant or award · Stock Options (Right to buy) | +4,402 | 4,402 | ||
| 2025-02-27 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +2,886 | 2,886 | ||
| 2025-02-27 | McLaughlin Vallerie Director | Grant or award · Stock Options (Right to buy) | +3,175 | 3,175 | ||
| 2025-02-27 | MATLIN DAVID J Director | Grant or award · Stock Options (Right to buy) | +5,628 | 5,628 | ||
| 2025-02-27 | Jacobovitz Shalom Director | Grant or award · Stock Options (Right to buy) | +4,293 | 4,293 | ||
| 2025-02-27 | Gay Jonathon Director | Grant or award · Stock Options (Right to buy) | +3,716 | 3,716 | ||
| 2025-02-27 | Desai Arjun JJ Director | Grant or award · Stock Options (Right to buy) | +3,319 | 3,319 | ||
| 2025-02-24 | Etherington Robert Dee Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +45,000 | 45,000 | ||
| 2025-02-24 | Mortenson Mark Chief Science Officer | Grant or award · Stock Options (Right to buy) | +40,000 | 40,000 | ||
| 2025-02-24 | BROWN MORGAN R Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +20,000 | 20,000 | ||
| 2024-12-06 | McLaughlin Vallerie Director | Grant or award · Stock Options (Right to buy) | +3,138 | 3,138 |
Page 9 of 15 · 292 trades